Thrive Capital

Thrive Capital Research Investment Thesis Thrive Capital is a New York-based venture capital firm founded by Joshua Kushner that invests in transformative technology and internet-enabled companies. The firm's core thesis is to back great founders building category-defining companies, regardless of stage. Thrive is known for its founder-first approach, patient capital deployment, and long-term conviction in transformative technologies. The firm manages approximately $15.57 billion in assets as of early 2025 and operates through multiple flagship funds (Fund IX and beyond) plus specialized vehicles like Thrive Holdings for permanent capital deployment. Investment Philosophy Thrive's approach is characterized by: High Conviction, Concentrated Portfolio : Unlike competitors that spread capital across many startups, Thrive makes fewer but more substantial bets. This allows deeper founder relationships and meaningful operational support beyond capital. Stage Agnostic : Thrive invests from pre-seed through pre-IPO, participating in rounds when they find exceptional founders and companies. They can write checks from $500K to $50M+ depending on the opportunity. Operational Support : Thrive partners with founders on operational challenges, hiring, board strategy, and company scaling. Joshua Kushner is known for a hands-on approach and deep engagement with portfolio companies. AI-First Focus : In recent years, Thrive has increasingly focused on AI and machine learning investments, from foundation models (Anthropic, OpenAI) to applied AI solutions across verticals. Portfolio Highlights and Recent Activity Historic Wins Instagram (acquired by Facebook for ~$1B) - early fund investment that validated thesis Spotify - significant early investor Slack - early stage investment Stripe - led Series B in 2012, follow-on investor Robinhood - led Series C at $1.3B valuation (2017), now worth $20B+ Warby Parker - Kushner co-founded, major portfolio company Oscar Health - Kushner co-founded, healthcare innovation Instacart - multi-stage investor Plaid - multi-stage investor, API infrastructure Airtable - multi-stage investor, low-code/no-code platform GitHub - 9% stake at time of acquisition by Microsoft Recent AI Investments (2025) OpenAI : $1B+ investment in Series E (December 2024) at $100B valuation; recent partnership with Thrive Holdings (December 2025) Anthropic : Participated in Series E $3.5B round (2025) Isomorphic Labs : Led $600M Series A (2025) - DeepMind spin-off for AI drug discovery Lila Sciences : Participated in $200M seed (2025) - AI-powered autonomous labs and scientific discovery ElevenLabs : Co-led $180M Series B (2025) - generative audio AI and voice synthesis Hugging Face : Strategic LP in Series D $235M round (2023) - open-source AI infrastructure Rogo : Series B $50M (2025) - AI copilot for investment banking workflows 2025 Activity Summary Active deployment from Fund IX ($5B+ fund closed 2021) Raising flagship fund with target of $6-8B (October 2025) Operating Thrive Holdings permanent capital vehicle with OpenAI partnership for AI-driven M&A and company building Deploying capital in Shield Technology Partners ($100M+) - AI-enabled IT services roll-up Sector and Stage Focus Primary Sectors: Software & Internet : B2B SaaS, developer tools, infrastructure Fintech & Payments : Financial services innovation Healthcare & Biotech : Digital health, AI-driven drug discovery AI & Machine Learning : Foundation models, applied AI, AI infrastructure Consumer Technology : High-growth consumer companies with network effects Stage Preferences: Thrive is stage-agnostic but has demonstrated strength across: Early-stage (pre-seed, seed): $500K-$5M typical tickets Growth stage (Series A-C): $5M-$30M typical tickets Late-stage (Series D+): $30M+ for winners they believe in Pre-IPO and public company stakes Check Size Range : $500K to $50M+ depending on stage and company quality Geographic Focus Primarily US-based with selective international exposure: Primary : San Francisco Bay Area, New York Secondary : Other US tech hubs (Seattle, Boston, Austin) Selective International : Europe (London, Berlin), Israel, and Asia for exceptional opportunities Team Structure Leadership: Joshua Kushner : Founder and Managing Partner - Founded at age 24 with $5M fund (2010), grew to $25B+ AUM Kareem Zaki : General Partner - Deep expertise in fintech, healthcare, and software; joined 2014; board member at multiple portfolio companies Thrive employs 109 people across investment, operations, and support functions including recruiting, brand, communications, and operations leadership. Fund Evolution Thrive's funding trajectory shows consistent growth: Fund I (2010) : $5-10M seed fund Fund II : $150M Fund III : $250M Fund IV (2016) : $1B Fund V-IX : Progressive increases to $5B+ for Fund IX (2021) Current : Raising Fund X (2025) targeting $6-8B Decision Process Investment Committee : Partnership-led decision making with Kushner and Zaki as key decision makers. Kushner has final say on major investments, reflecting his hands-on founder-focused approach. Due Diligence : Thrive conducts deep founder and market analysis. They move quickly for founders they believe in, often with founder-first term sheets and minimal bureaucracy. Decision Timeline : Typically 2-4 weeks for early stage, 1-2 months for growth/late stage depending on complexity. Warm Introductions Warm introductions are strongly preferred. Thrive receives high volume of inbound and prioritizes warm intros from trusted founders, operators, and advisors in their network. Cold outreach is reviewed but lower priority. Founder Preferences Thrive backs founders who demonstrate: Exceptional talent and vision : Category-defining thinking Operational excellence : Can execute at scale Market insight : Deep understanding of their domain Resilience : Ability to navigate challenges and adapt Communication : Can articulate vision and strategy clearly Kushner is known for backing founder-operators and has particular appreciation for founders with: Prior successful exits or operating experience Technical depth for infrastructure/SaaS plays Consumer insight for consumer-facing plays Healthcare/biotech expertise for healthcare investments Competitive Advantages Brand and Network : Kushner's reputation and relationships across tech ecosystem Patient Capital : 15+ year fund durations allow support through multiple market cycles Operating Support : Beyond capital, hands-on help with scaling, hiring, fundraising Multi-stage Participation : Can support winners from seed through pre-IPO and beyond Permanence : Thrive Holdings provides permanent capital for acquisitions and roll-ups AI Expertise : Recent focus and successful bets in AI positioning them as domain experts Exit Patterns Strong Exit Track Record: Successful IPOs: Spotify (listed at $165/share valuation ~$26B), Robinhood (public, $20B+ market cap) Successful M&A: Instagram ($1B), GitHub (Microsoft, $7.5B), Twitch (Amazon) Still Private Winners: Stripe ($95B+ valuation), Plaid ($13B+ valuation) Thrive's exits reflect strong returns and ability to back breakout companies. Recent Strategic Moves (2025) Thrive Holdings Permanent Capital Arm : Deploying capital to acquire and consolidate companies in underserving sectors (accounting, IT services) to implement AI and automation OpenAI Partnership : Joint partnership to deploy Shield Technology Partners and explore additional AI-enabled M&A opportunities Fund X Fundraising : Raising $6-8B flagship fund to continue deployment in AI and transformative technologies Multi-stage Focus : Maintaining flexibility to support winners across all stages as founding of breakout companies requires Investment Criteria Summary Must-Haves: Exceptional founder(s) with clear vision Large addressable market Clear path to category leadership Strong product-market fit signals (for growth stage+) Preferred: Founder with operating experience or technical depth Network effects or strong defensibility Predictable unit economics Experienced management team for late-stage Avoid: Unclear market opportunity Execution risks with inexperienced teams Commodity-like products without differentiation Unsustainable unit economics Fund Deployment Status As of late 2025, Thrive is in active deployment phase: Fund IX ($5B+) continues to deploy aggressively Fund X ($6-8B target) in fundraising process Thrive Holdings permanent capital making strategic acquisitions Portfolio company exits continuing to generate returns The firm is optimally positioned to support founders across stages with patient capital, operational expertise, and deep network access.